
|Articles|October 1, 2003
CIBA Vision echoes Pfizer's call for surgical business buyers
Author(s)Jennifer A. Webb
Duluth, GA-Less than a month after Pfizer Inc. announced it would consider selling off the surgical business it acquired with its merger with Pharmacia Corp. (Ophthalmology Times, Sept. 1 issue, Page 3), another large manufacturer of ophthalmic surgical products has announced it is pondering selling the surgical segment of its business as well.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
AAO 2025: Philip J. Ferrone, MD, highlights safety and efficacy findings of gildeuretinol in Stargardt disease
2
Preclinical study suggests synaptic regeneration may offer new pathway to treat glaucoma
3
AAO 2025: The evolution of eye care on display at AAO 2025
4
AAO 2025: Trial demonstrates safety and efficacy of epithelium-on cross linking
5